Thought Leader:

Sheila Rocchio, Chief Marketing Officer, eClinical Solutions

May 25, 2021

In this episode, Sheila Rocchio speaks about the latest trends in clinical trial technology including decentralized and digital trials. We discussed the industry enthusiasm around reducing cycle times and both the technology challenges and opportunities that new data sources … Read More »

Thought Leader:

Dave Heckard, EVP, at HRA - Healthcare Research and Analytics, a part of Truth Serum NTWK™

April 30, 2021

In this episode, Dave Heckard talks about KOLs, how to find them, recruit them, and utilize them for your life sciences products.

Thought Leader:

Jonathan Andrus, Chief Business Officer, Clinical Ink

March 31, 2021

In this episode, Jonathan Andrus talks about clinical trial data collection, including EDC, DDC, and BYOD. There is also a related white paper on BYOD, which you can download using the link below.

Thought Leaders:

Chandler Goodman, Director, Thought Leadership, Gagen MacDonald
Hillary Goodman, Managing Director. Gagen MacDonald

December 11, 2020

When it comes to business transformations, failure is the norm. But is that really how it has to be? In this thought-provoking podcast, Chandler Goodman and Hillary Goodman of Gagen MacDonald share stories and insights from their experiences supporting business leaders throu … Read More »

Thought Leaders:

Leena Dalal, Vice President Brand Marketing at Alnylam
Kristin Morris, Creative Director at Dudnyk – a member of Fishawack Health.

October 19, 2020

Fishawack Health speaks to Leena Dalal, Vice President Brand Marketing at Alnylam, to reveal the untold story behind ONPATTRO, a ground-breaking therapy for ultra-rare disease hATTR amyloidosis. Then Kristin Morris, Creative Director at Dudnyk – a member of Fishawack Health … Read More »

Thought Leader:

Yadin Shemmer, Senior Vice President of Mango Health, a
TrialCard company

October 12, 2020

In this episode, we talk about the key pain points for patients and pharmaceutical brands across the patient journey. We also discuss how patient support programs benefit from mobile technology and how Mango Health is addressing the needs of the patient and the pharma compan … Read More »

Thought Leaders:

Mark Boesen, Pharm.D., J.D., Director of Pharmacy, TC Script LLC
Paul LeVine, VP of Business Partnerships, Mango Health, a TrialCard company

September 23, 2020

In this episode, we talk about how COVID-19 has impacted the pharmaceutical industry, as well as trends and predictions about the future of patient assistance programs and distribution of medications.

Thought Leaders:

Cory Johnson, National Sales Manager, TrialCard
Bobby Lewis, National Sales Manager, TrialCard

September 15, 2020

In this episode, I meet with Cory Johnson and Bobby Lewis, National Sales Managers at TrialCard. We talk about how virtual engagement is changing the way brands communicate with HCPs in order to increase sales.

Thought Leaders:

Jacylyn Bodmer, Chief Information & Technology Officer
Rebecca Kush, Ph.D., Chief Scientific Officer

August 10, 2020

In this episode, experts from Elligo Health Research talk about how clinical research must change to adapt to a pandemic. They also discuss using technology to change the research paradigm, the rise of decentralized trials, ways to better support patients, clinicians, and st … Read More »

Thought Leader:

Jonathan Andrus, Chief Business Officer, Clinical Ink

May 28, 2020

With COVID-19, the value of virtual trials with direct data capture (DDC) is obvious. Bring-your-own-device (BYOD) electronic patient-reported outcome (ePRO) solutions increase adherence while precluding the transfer of devices among patients. This white paper covers a Phase … Read More »

Thought Leaders:

Dan Chichester, Chief Experience Officer, Ogilvy Health
Amy Graham, Client Engagement Officer, Ogilvy Health
Ritesh Patel, Chief Digital Officer – Health, Ogilvy Health
Joe Youssef, Associate Director, Engagement Strategy, Ogilvy Health

April 22, 2020

For our 2020 Year in Preview issue, we asked 20 provocative questions covering a range of topics from molecule to market. We wanted to push the envelope to understand how the industry’s influencers think about aspirational goals in terms of health, what needs to happen to ad … Read More »

Thought Leaders:

Mohammad Yaghoubi, M.D., Chief Medical Officer at 81qd
Wes Michael, President and Founder of Rare Patient Voice

February 26, 2020

In this episode, Mohammad Yaghoubi, M.D., Chief Medical Officer at 81qd sits down with Wes Michael, President and Founder of Rare Patient Voice. They discuss the role of AI to support diagnosis and other issues related to improved patient care. Read the related white paper o … Read More »

Thought Leader:

Dr. Janine Collins, Executive Director, Safety, Epidemiology, Registries and Risk Management

December 17, 2019

In this podcast, UBC’s Dr. Janine Collins, speaks to the importance of risk management plans and key considerations and benefits of partnering to develop and implement a global risk management plan.

Thought Leader:

Eli Phillips Jr, PharmD, JD, Vice President, Insights & Engagement and Regulatory Sciences, Cardinal Health

October 11, 2019

The field of medicine is becoming increasingly precise with new advanced therapies that target disease at a cellular level and healthcare providers who are becoming “micro-specialists” in their fields. As care becomes more precise, so must the efforts to commercialize new dr … Read More »

Thought Leader:

Andrew Schirmer, CEO, Ogilvy Health

September 24, 2019

Andrew Schirmer discusses a grander plan for healthcare agencies as the industry evolves.

Thought Leader:

Bonnie Overton, Group Associate Creative Director, MicroMass Communications

August 23, 2019

In this episode, we talk about how behavioral science is addressing some of pharma’s biggest challenges.

Thought Leaders:

Anita Nelsen, Vice President, Translational Medicine, Parexel
Angela Qu, Senior Director, Biomarkers & Genomic Medicine, Parexel

July 2, 2019

The process of drug development is not on a sustainable path forward. The system is inefficient, lengthy and costly. Despite the rising costs of R&D, failure rates are as high as 90% and the average time to market now takes approximately 12 years. Companies are hard pres … Read More »

FEEDBACK